[1]
|
Seung, K.J., Omatayo, D.B., Keshavjee, S., Furin, J.J., Farmer, P.E., et al. (2009) Early Outcomes of MDR-TB Treatment in a High HIV-Prevalence Setting in Southern Africa. PLoS ONE, 4, Article: e7186.
http://dx.doi.org/10.1371/journal.pone.0007186
|
[2]
|
Calver, A.D., Falmer, A.A., Murray, M., Strauss, O.J., Streicher, E.M., et al. (2010) Emergence of Increased Resistance and Extensively Drug-Resistant Tuberculosis despite Treatment Adherence, South Africa. Emerging Infectious Diseases, 16, 264-271. http://dx.doi.org/10.3201/eid1602.090968
|
[3]
|
Hassim, S., Shaw, P.A., Sangweni, P., Malan, L., Ntshani, E., et al. (2010) Detection of a Substantial Rate of Multidrug-Resistant Tuberculosis in an HIV-Infected Population in South Africa by Active Monitoring of Sputum Samples. Clinical Infectious Diseases, 50, 1053-1059. http://dx.doi.org/10.1086/651119
|
[4]
|
Gandhi, N.R., Shah, N.S., Andrews, J.R., Vella, V., Moll, A.P., et al. (2010) HIV Co-Infection in Multidrug- and Extensively Drug-Resistant Tuberculosis Results in High Early Mortality. American Journal of Respiratory and Critical Care Medicine, 181, 80-86. http://dx.doi.org/10.1164/rccm.200907-0989OC
|
[5]
|
Dheda, K., Shean, K., Zumla, A., Badri, M., Streicher, E.M., et al. (2010) Early Treatment Outcomes and HIV Status of Patients with Extensively Drug-Resistant Tuberculosis in South Africa: A Retrospective Cohort Study. Lancet, 375, 1798-1807. http://dx.doi.org/10.1016/S0140-6736(10)60492-8
|
[6]
|
WHO (2012) Tuberculosis Global Facts. www.who.int/tb
|
[7]
|
Agonafi, M., et al. (2010) Phenotypic and Genotypic Analysis of Multidrug-Resistant Tuberculosis in Ethiopia. International Journal of Tuberculosis and Lung Disease, 14, 1259-1265.
|
[8]
|
WHO (2010) Multidrug and Extensively Drug-Resistant TB (M/XDR-TB): Global Report on Surveillance and Response.
|
[9]
|
Demissie, M., Gebeyehu, M. and Berhane, Y. (2005) Primary Resistance to Anti-Tuberculosis Drugs. International Journal of Tuberculosis and Lung Disease, 1, 64-67.
|
[10]
|
Abate, G., Miörner, H., Ahmed, O. and Hoffner, S.E. (2006) Drug Resistance in Mycobacterium Tuberculosis Strains Isolated from Re-Treatment Cases of Pulmonary Tuberculosis: Susceptibility to First-Line and Alternative Drugs. International Journal of Tuberculosis and Lung Disease, 2, 580-584.
|
[11]
|
Meskel, D.W., Abate, G., Lakew, M., Goshu, S. and Aseffa, A. (2008) Anti-Tuberculosis Drug Resistance among Retreatment Patients. Ethiopian Medical Journal, 46, 219-225.
|
[12]
|
Addis Ababa Regional Health Bureau (AARHB) (2010) Operational Manual for Regional HIV/AIDS Care and Treatment Catchments Team Activities.
|
[13]
|
Ethiopian Federal Ministry of Health and Federal HIV/AIDS Prevention and Control Office (2007) Single Point HIV Prevalence Estimate.
|
[14]
|
FMOH (2008) Tuberculosis, Leprosy and TB/HIV Prevention and Control Programme. Addis Ababa.
|
[15]
|
Addis Ababa HIV/AIDS Prevention & Control Office (2009) Anti-Retroviral Treatment (ART) Sites.
|
[16]
|
Liang, L.B., Wu, Q.H., Gao, L.J., Hao, Y.H., Liu, C.J., Xie, Y.G., et al. (2012) Factors Contributing to the High Prevalence of Multidrug-Resistant Tuberculosis: A Study from China. Thorax, 67, e632-e638.
http://dx.doi.org/10.1136/thoraxjnl-2011-200018
|
[17]
|
Merza, M.A., et al. (2011) Anti-Tuberculosis Drug Resistance and Associated Risk Factors in a Tertiary Level TB Centre in Iran. Journal of Infection in Developing Countries, 5, 511-519. http://dx.doi.org/10.3855/jidc.1259
|
[18]
|
Gler, M.T. (2012) Impact of Patient and Program Factors on Default during Treatment of Multidrug-Resistant Tuberculosis. International Journal of Tuberculosis and Lung Disease, 16, 955-960. http://dx.doi.org/10.5588/ijtld.11.0502
|
[19]
|
Bushra, A.W. (2012) Risk Factors for Multi-Drug Resistant TB (MDR-TB) among Tuberculosis Patients in Saint Peter TB Specialized Hospital.
|
[20]
|
Casal, M. (2005) A Case-Control Study for Multidrug-Resistant Tuberculosis: Risk Factors in Four European Countries. Microbial Drug Resistance, 11, 62-67. http://dx.doi.org/10.1089/mdr.2005.11.62
|